Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Sep-17 7:14 PM View:  | Thompson John Craig President & CEO Director | Anthera Pharmaceuticals Inc (ANTH) | 20-Sep-17 | Market Purchase | 8,550 | $1.32 | $11,286.00 | 76% 11.3K to 19.85K | (93%) |
| 07-Sep-17 6:56 PM View: | Truex Paul F Director | Anthera Pharmaceuticals Inc (ANTH) | 07-Sep-17 | Market Purchase | 5,000 | $1.34 | $6,700.00 | 42% 11.79K to 16.79K | (93%) |
| 07-Sep-17 2:43 PM View: | Thompson John Craig President & CEO Director | Anthera Pharmaceuticals Inc (ANTH) | 07-Sep-17 | Option Exercise | 10,400 | $1.43 | $14,892.80 | 145% 7.19K to 17.59K | (93%) |
| 06-Feb-17 10:00 PM View: | Olson Charles V CHIEF TECHNOLOGY OFFICER | Anthera Pharmaceuticals Inc (ANTH) | 11-Jan-17 | Grant | 7,767 | $0.55 | $4,271.85 | 80% 9.75K to 17.52K | |
| 06-Feb-17 10:00 PM View: | Thompson John Craig Chief Executive Officer | Anthera Pharmaceuticals Inc (ANTH) | 11-Jan-17 | Grant | 7,190 | $0.55 | $3,954.50 | 100% 0 to 7.19K | |
| 22-Sep-16 7:29 PM View: | Truex Paul F Chief Executive Officer | Anthera Pharmaceuticals Inc (ANTH) | 20-Sep-16 | Gift | 5,008 | -- | -- | 6% 89.34K to 94.34K | |
| 22-Sep-16 7:29 PM View: | Truex Paul F Chief Executive Officer | Anthera Pharmaceuticals Inc (ANTH) | 20-Sep-16 | Gift | 5,008 | -- | -- | (5%) 99.35K to 94.34K | |
| 22-Sep-16 7:29 PM View: | Truex Paul F Chief Executive Officer | Anthera Pharmaceuticals Inc (ANTH) | 20-Sep-16 | Option Exercise | 5,008 | $2.08 | $10,416.60 | 5% 94.34K to 99.35K | |
| 06-Feb-17 10:00 PM View: | Olson Charles V CHIEF TECHNOLOGY OFFICER | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-16 | Grant | 1,789 | $2.63 | $4,705.07 | 22% 7.96K to 9.75K | |
| 24-Dec-15 12:35 PM View: | Mueller Brian Director | Anthera Pharmaceuticals Inc (ANTH) | 23-Dec-15 | Option Exercise | 10,000 | $2.89 | $28,900.00 | 100% 0 to 10.0K | |
| 18-Nov-15 6:53 PM View: | Hislop Colin Chief Medical Officer | Anthera Pharmaceuticals Inc (ANTH) | 13-Nov-15 | Market Option Sale | 12,500 | $5.31 | $66,341.20 | (37%) 33.54K to 21.04K | 100% |
| 18-Nov-15 6:53 PM View: | Hislop Colin Chief Medical Officer | Anthera Pharmaceuticals Inc (ANTH) | 13-Nov-15 | Option Exercise | 12,500 | $1.61 | $20,125.00 | 59% 21.04K to 33.54K | |
| 12-Nov-15 4:21 PM View: | Hislop Colin Chief Medical Officer | Anthera Pharmaceuticals Inc (ANTH) | 11-Nov-15 | Market Sale | 5,000 | $5.38 | $26,900.00 | (19%) 26.04K to 21.04K | 100% |
| 13-Oct-15 8:02 PM View: | Odink Debra Chief Technology Officer | Anthera Pharmaceuticals Inc (ANTH) | 12-Oct-15 | Market Sale (Planned) | 1,205 | $6.15 | $7,410.75 | (5%) 22.96K to 21.75K | 100% |
| 23-Dec-15 6:08 AM View: | Truex Paul F Chief Executive Officer | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-15 | Gift | 12,500 | -- | -- | (11%) 114.34K to 101.84K | |
| 23-Dec-15 6:08 AM View: | Truex Paul F Chief Executive Officer | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-15 | Acquisition (other) | 12,500 | -- | -- | 12% 101.84K to 114.34K | |
| 11-Jan-16 2:00 PM View: | Dickinson Klara SVP & Chief Regulatory Office | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-15 | Grant | 12,500 | $1.49 | $18,625.00 | 100% 0 to 12.5K | |
| 23-Dec-15 6:07 AM View: | Liu May SVP, Finance & Administration | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-15 | Grant | 12,500 | $1.49 | $18,625.00 | 63% 19.8K to 32.3K | |
| 23-Dec-15 6:08 AM View: | Truex Paul F Chief Executive Officer | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-15 | Disposition (other) | 12,500 | -- | -- | (12%) 101.84K to 89.34K | |
| 23-Dec-15 6:08 AM View: | Truex Paul F Chief Executive Officer | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-15 | Grant | 12,500 | $1.49 | $18,625.00 | 14% 89.34K to 101.84K | |
| 02-Jan-15 6:33 PM View: | Truex Paul F President and CEO | Anthera Pharmaceuticals Inc (ANTH) | 31-Dec-14 | Gift | 12,500 | -- | -- | 12% 101.84K to 114.34K | |
| 02-Jan-15 6:33 PM View: | Truex Paul F President and CEO | Anthera Pharmaceuticals Inc (ANTH) | 31-Dec-14 | Gift | 12,500 | -- | -- | (11%) 114.34K to 101.84K | |
| 02-Jan-15 6:36 PM View: | Odink Debra Chief Technology Officer | Anthera Pharmaceuticals Inc (ANTH) | 30-Dec-14 | Gift | 1,364 | -- | -- | (6%) 24.32K to 22.96K | |
| 02-Jan-15 6:36 PM View: | Odink Debra Chief Technology Officer | Anthera Pharmaceuticals Inc (ANTH) | 30-Dec-14 | Gift | 1,364 | -- | -- | 6% 22.96K to 24.32K | |
| 01-Jul-14 8:09 PM View: | Truex Paul F President and CEO | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-14 | Gift | 16,500 | -- | -- | (27%) 60.63K to 44.13K | |
| 01-Jul-14 8:09 PM View: | Truex Paul F President and CEO | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-14 | Disposition (other) | 14,709 | -- | -- | (33%) 44.13K to 29.42K | |
| 01-Jul-14 8:09 PM View: | Truex Paul F President and CEO | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-14 | Option Exercise | 2,000 | $2.08 | $4,160.00 | 3% 59.33K to 61.33K | |
| 01-Jul-14 8:09 PM View: | Truex Paul F President and CEO | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-14 | Payment of Exercise | 699 | $3.39 | $2,369.61 | (1%) 61.33K to 60.63K | 100% |
| 27-Mar-14 9:58 PM View: | Hislop Colin Chief Medical Officer | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-14 | Grant | 3,864 | -- | -- | 15% 25.5K to 29.37K | |
| 27-Mar-14 9:58 PM View: | Hislop Colin Chief Medical Officer | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-14 | Payment of Exercise | 3,323 | -- | -- | (11%) 29.37K to 26.04K | |
| 27-Mar-14 9:57 PM View: | Liu May Chief Accounting Officer | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-14 | Grant | 3,625 | -- | -- | (32%) 11.46K to 7.83K | |
| 27-Mar-14 9:56 PM View: | Truex Paul F President and CEO | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-14 | Grant | 3,864 | -- | -- | < 1% 608.49K to 612.36K | |
| 27-Mar-14 9:57 PM View: | Odink Debra Chief Technology Officer | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-14 | Grant | 3,864 | -- | -- | (13%) 29.6K to 25.74K | |
| 27-Mar-14 9:56 PM View: | Truex Paul F President and CEO | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-14 | Payment of Exercise | 7,622 | $3.30 | $25,152.60 | (1%) 618.61K to 610.98K | 100% |
| 27-Mar-14 9:56 PM View: | Truex Paul F President and CEO | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-14 | Grant | 6,250 | $3.30 | $20,625.00 | 1% 612.36K to 618.61K | (100%) |
| 27-Mar-14 9:57 PM View: | Odink Debra Chief Technology Officer | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-14 | Payment of Exercise | 2,783 | $3.30 | $9,183.90 | (11%) 25.74K to 22.96K | 100% |
| 27-Mar-14 9:57 PM View: | Liu May Chief Accounting Officer | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-14 | Payment of Exercise | 529 | $3.30 | $1,745.70 | (7%) 7.83K to 7.3K | 100% |
| 02-Jul-13 9:17 PM View: | Odink Debra Chief Technology Officer | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-13 | Payment of Exercise | 2,248 | $0.49 | $1,101.52 | (1%) 177.26K to 175.01K | 100% |
| 02-Jul-13 9:17 PM View: | Liu May Chief Accounting Officer | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-13 | Payment of Exercise | 675 | $0.49 | $330.75 | (2%) 34.33K to 33.66K | 100% |
| 26-Jun-13 5:24 PM View: | Thompson David E. Director | Anthera Pharmaceuticals Inc (ANTH) | 24-Jun-13 | Market Purchase | 100,000 | $0.53 | $53,000.00 | 355% 28.2K to 128.2K | (100%) |
| 04-Jun-13 7:26 PM View: | Dziurzynskio Bogdan Director | Anthera Pharmaceuticals Inc (ANTH) | 31-May-13 | Market Purchase | 10,000 | $0.59 | $5,900.00 | 100% 0 to 10.0K | (100%) |
| 21-May-13 9:31 PM View: | Truex Paul F President and CEO | Anthera Pharmaceuticals Inc (ANTH) | 21-May-13 | Gift | 100,000 | -- | -- | (12%) 827.18K to 727.18K | |
| 27-Mar-13 9:22 PM View: | Truex Paul F President and CEO | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-13 | Grant | 135,644 | -- | -- | 20% 691.54K to 827.18K | |
| 27-Mar-13 9:20 PM View: | Odink Debra Chief Technology Officer | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-13 | Grant | 49,519 | -- | -- | 39% 127.74K to 177.26K | |
| 27-Mar-13 9:19 PM View: | Hislop Colin Chief Medical Officer | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-13 | Grant | 59,132 | -- | -- | 59% 100.14K to 159.27K | |
| 27-Mar-13 9:20 PM View: | Lowe Christopher P. CFO and Chief Business Officer | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-13 | Grant | 67,579 | -- | -- | 163% 41.34K to 108.92K | |
| 01-Feb-13 8:19 PM View: | Orbimed Advisors LLC Director | Anthera Pharmaceuticals Inc (ANTH) | 30-Jan-13 | Market Purchase | 5,700,000 | $0.66 | $3,762,000.00 | 323% 1.76M to 7.46M | (100%) |
| 29-Jan-13 4:54 PM View: | Orbimed Advisors LLC Director | Anthera Pharmaceuticals Inc (ANTH) | 25-Jan-13 | Market Purchase | 1,762,000 | $0.65 | $1,142,480.00 | 100% 0 to 1.76M | (100%) |
| 11-Jan-13 5:39 PM View: | Odink Debra Chief Technology Officer | Anthera Pharmaceuticals Inc (ANTH) | 10-Jan-13 | Gift | 4,009 | -- | -- | 3% 127.74K to 131.75K | |
| 11-Jan-13 5:39 PM View: | Odink Debra Chief Technology Officer | Anthera Pharmaceuticals Inc (ANTH) | 10-Jan-13 | Gift | 4,009 | -- | -- | (3%) 131.75K to 127.74K |
